Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02813317
Other study ID # IC 2014-11
Secondary ID
Status Completed
Phase N/A
First received January 6, 2016
Last updated April 12, 2017
Start date December 2014
Est. completion date April 2017

Study information

Verified date April 2017
Source Institut Curie
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This prospective, multicenter, observational study aims to explore a comprehensive approach to the care of early breast cancer patients in a regional health territory (including 1.5 million women and characterized by a breast cancer incidence and mortality higher than national ranges), incorporating all healthcare actors inside and outside the hospital.


Description:

The treatment course of a breast cancer patient includes a hospital stay, home health care that requires outpatient services, supportive care and a follow-up course. Outpatient surgery and home hospitalization units are two innovative organizational technologies that are strongly recommended because of their putative positive medico-economic impact; however, these structures are poorly studied in terms of quality of care and patient satisfaction. Regional implementation of these innovations is heterogeneous, thus allowing a comparative study.

This prospective, multicenter, observational study aims to explore a comprehensive approach to the care of early breast cancer patients in a regional health territory (including 1.5 million women and characterized by a breast cancer incidence and mortality higher than national ranges), incorporating all healthcare actors inside and outside the hospital.

This study will be conducted in academic centers, general hospitals and private centers. In the different participating centers, the implemented care steps are different and may include outpatient surgery, home hospitalization, a one-stop breast clinic visit, care by an oncology pivot nurse and/or screening for supportive care. Outpatient surgery and home hospitalization in particular are two health technologies that are validated by the French National Authority for Health but used differently in different centers.

The primary objective is to examine the economic and financial measurements of the different care pathways of early breast cancer patients to compare the economic burden of outpatient surgery and home hospitalization with the conventional care pathway.

The secondary objectives are:

Assessing patient satisfaction and needs for supportive care. Evaluating the structures and organizations. Evaluating the tool exchanges between the actors over the treatment course.

All parameters related to the patient and to disease characteristics, determinants and management characteristics within and outside the center within one year will be collected and centralized in the study database. The patients' course of care will be divided into five stages: preadmission, hospitalization, the postoperative period (+ 1 month), adjuvant treatments and one-year follow-up. Care pathways will be identified, described and analyzed to meet the primary objective and the secondary objectives.

After analyzing these care pathways, we will propose solutions for optimizing hospital and nonhospital care, thereby building efficient connections among the hospital, home health care, district nurse networks, medical and social sectors, and occupational reintegration.


Recruitment information / eligibility

Status Completed
Enrollment 617
Est. completion date April 2017
Est. primary completion date February 2017
Accepts healthy volunteers No
Gender Female
Age group 18 Years and older
Eligibility Inclusion Criteria:

1. Signed written informed consent.

2. Patients aged =18 years.

3. Previously untreated, operable breast cancer

4. Affiliation with the social security system (or a similar coverage)

5. Patient living in one of these french department : "Hauts-de-Seine (92)", "les Yvelines (78)", or "le Val d'Oise (95)".

6. Female gender.

Exclusion Criteria:

1. Previous history of breast cancer.

2. Metastatic, locally advanced, or inflammatory breast cancer, as defined by the AJCC (American Joint Committee on Cancer, 7th Edition).

3. Any prior treatment for primary breast cancer.

4. Patient with any psychological, sociological or geographical condition potentially hampering compliance with the study follow-up schedule.

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
France Victor Dupouy Hospital Argenteuil
France Antoine Béclère Hospital Clamart
France Louis Mourier Hospital Colombes
France André Mignot Hospital - Versailles Le Chesnay
France Bichat Beaujon University Hospital Paris
France Institut Curie Paris
France Poissy Interegional Hospital Center Poissy
France René Dubos Hospital Pontoise
France Institut Curie - René Huguenin Hospital Saint-Cloud

Sponsors (1)

Lead Sponsor Collaborator
Institut Curie

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Other Care pathways suggestion for a regional health territory. After analyzing these care pathways, we will propose solutions for optimizing hospital and nonhospital care, thereby building efficient connections among the hospital, home health care, district nurse networks, medical and social sectors, and occupational reintegration. Through study completion (within one year after the last patient follow-up)
Primary Care pathways description of early breast cancer patients. Care pathways will be characterized by the sequence of different care steps. Care steps may include : outpatient surgery, home hospitalization, a one-stop breast clinic visit, care by an oncology pivot nurse and/or screening for supportive care. Up to one year after patient registration
Primary Overall cost measurements of the different care pathways. Evaluating the overall costs of the pathway care (health care and supportive care consumption) at one year for the different perspectives. Up to one year after patient registration
Primary Overall cost measurements of the different care pathways for health insurance Evaluating the indirect costs of health insurance Up to one year after patient registration
Primary Overall cost measurements of the different care pathways for the patient Evaluating the out-of-pocket health expenses for breast cancer during the first year post diagnosis (direct and indirect costs). Up to one year after patient registration
Secondary Patient satisfaction evaluation Patient satisfaction will be assessed at different time points using the OUT-PATSAT35 questionnaire validated in French. Up to one year after patient registration.
Secondary Supportive care needs assessement The patient's needs for supportive care will be assessed using the Supportive Care Needs Survey - Breast Cancer module (SCNS-BR8) validated in French. Up to one year after patient registration
Secondary Supportive care needs assessement The patient's needs for supportive care will be assessed using the Supportive Care Needs Survey Short Form (SCNS-SF34) validated in French. Up to one year after patient registration
Secondary Breast cancer impact on patient's professional activity Evaluating patient return to work : Existence of an occupational reintegration or not. Up to one year after patient registration.
Secondary Breast cancer impact on patient's professional activity Evaluating patient return to work : Date of return to work Up to one year after patient registration.
Secondary Breast cancer impact on patient's professional activity Evaluating patient return to work : Organization of working time description Up to one year after patient registration.
Secondary Breast cancer impact on patient's professional activity Evaluating patient return to work : Number of days out of work Up to one year after patient registration.
Secondary Structures and organizations interactions description Identification of health care actors inside and outside the hospital Up to one year after patient registration
Secondary Structures and organizations interactions description identification of the interactions between the organizations (e.g., identification, shared tools, resource sharing and nurse training). Up to one year after patient registration
Secondary Structures and organizations interactions description Regular practitioners questionnaires Up to one year after patient registration
See also
  Status Clinical Trial Phase
Recruiting NCT04681911 - Inetetamab Combined With Pyrotinib and Chemotherapy in the Treatment of HER2 Positive Metastatic Breast Cancer Phase 2
Terminated NCT04066790 - Pyrotinib or Trastuzumab Plus Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer Phase 2
Completed NCT04890327 - Web-based Family History Tool N/A
Completed NCT03591848 - Pilot Study of a Web-based Decision Aid for Young Women With Breast Cancer, During the Proposal for Preservation of Fertility N/A
Recruiting NCT03954197 - Evaluation of Priming Before in Vitro Maturation for Fertility Preservation in Breast Cancer Patients N/A
Terminated NCT02202746 - A Study to Assess the Safety and Efficacy of the VEGFR-FGFR-PDGFR Inhibitor, Lucitanib, Given to Patients With Metastatic Breast Cancer Phase 2
Active, not recruiting NCT01472094 - The Hurria Older PatiEnts (HOPE) With Breast Cancer Study
Completed NCT06049446 - Combining CEM and Magnetic Seed Localization of Non-Palpable Breast Tumors
Withdrawn NCT06057636 - Hypnosis for Pain in Black Women With Advanced Breast Cancer: A Feasibility Study N/A
Recruiting NCT05560334 - A Single-Arm, Open, Exploratory Clinical Study of Pemigatinib in the Treatment of HER2-negative Advanced Breast Cancer Patients With FGFR Alterations Phase 2
Active, not recruiting NCT05501769 - ARV-471 in Combination With Everolimus for the Treatment of Advanced or Metastatic ER+, HER2- Breast Cancer Phase 1
Recruiting NCT04631835 - Phase I Study of the HS-10352 in Patients With Advanced Breast Cancer Phase 1
Completed NCT04307407 - Exercise in Breast Cancer Survivors N/A
Recruiting NCT03544762 - Correlation of 16α-[18F]Fluoro-17β-estradiol PET Imaging With ESR1 Mutation Phase 3
Terminated NCT02482389 - Study of Preoperative Boost Radiotherapy N/A
Enrolling by invitation NCT00068003 - Harvesting Cells for Experimental Cancer Treatments
Completed NCT00226967 - Stress, Diurnal Cortisol, and Breast Cancer Survival
Recruiting NCT06019325 - Rhomboid Intercostal Plane Block on Chronic Pain Incidence and Acute Pain Scores After Mastectomy N/A
Recruiting NCT06037954 - A Study of Mental Health Care in People With Cancer N/A
Recruiting NCT06006390 - CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors Phase 1/Phase 2